OCTOPUS INVESTMENTS LTD disclosed a 7.47% interest in Advanced Medical Solutions Group plc under Rule 8.3 of the Takeover Code. The position, held as of 24/08/2026, comprised 16,503,102 ordinary 5p shares identified by ISIN GB0004536594. The filing reported a sale of 15,940 shares at 2.8125 per share, a cancelled in-specie transfer out of 150 shares reinstated to the portfolio, and an in-specie transfer out of 3,350 shares. No short positions, derivatives, subscription rights, other offer parties, indemnities, dealing arrangements, or agreements relating to options or derivatives were disclosed. No Supplemental Form 8 was attached. The disclosure was dated 25/08/2026, with Robbie Campbell listed as the contact.